BRICS Needle-Free Injectors Market Outlook (2022-2033)
The BRICS Needle-free Injectors Market size is expected to reach US$ 4,847.0 million by 2033 from US$ 2,471.9 million in 2025. The market is estimated to record a CAGR of 8.8 % from 2026 to 2033.
Report Coverage
- Product: Liquid Jet Injectors, Powder Jet Injectors, Spring-Powered / Gas-Powered Injectors, Other products
- Usability: Disposable, Reusable
- Application: Cancer, Autoimmune Disorders, Hormonal Disorders, Pain Management, Other Applications
US$ 2,471.9 Mn
Market size in 2025
US$ 4,847.0 Mn
Market Size by 2033
8.8%
CAGR, 2026 - 2033
2026-2033
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. BRICS Needle-Free Injectors Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. BRICS Needle-Free Injectors Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. BRICS Needle-Free Injectors Market Regional Analysis
6.2 BRICS Needle-Free Injectors Market Revenue 2022-2033 (US$ Million)
6.3 BRICS Needle-Free Injectors Market Forecast Analysis
7. BRICS Needle-Free Injectors Market Analysis – by Product
7.1 Liquid Jet Injectors
- 7.1.1 Overview
- 7.1.2 Liquid Jet Injectors: BRICS Needle-Free Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)
7.2 Powder Jet Injectors
- 7.2.1 Overview
- 7.2.2 Powder Jet Injectors: BRICS Needle-Free Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)
7.3 Spring-Powered / Gas-Powered Injectors
- 7.3.1 Overview
- 7.3.2 Spring-Powered / Gas-Powered Injectors: BRICS Needle-Free Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)
7.4 Other products
- 7.4.1 Overview
- 7.4.2 Other products: BRICS Needle-Free Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)
8. BRICS Needle-Free Injectors Market Analysis – by Usability
8.1 Disposable
- 8.1.1 Overview
- 8.1.2 Disposable: BRICS Needle-Free Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)
8.2 Reusable
- 8.2.1 Overview
- 8.2.2 Reusable: BRICS Needle-Free Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)
9. BRICS Needle-Free Injectors Market Analysis – by Application
9.1 Cancer
- 9.1.1 Overview
- 9.1.2 Cancer: BRICS Needle-Free Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)
9.2 Autoimmune Disorders
- 9.2.1 Overview
- 9.2.2 Autoimmune Disorders: BRICS Needle-Free Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)
9.3 Hormonal Disorders
- 9.3.1 Overview
- 9.3.2 Hormonal Disorders: BRICS Needle-Free Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)
9.4 Pain Management
- 9.4.1 Overview
- 9.4.2 Pain Management: BRICS Needle-Free Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)
9.5 Other Applications
- 9.5.1 Overview
- 9.5.2 Other Applications: BRICS Needle-Free Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)
10. BRICS Needle-Free Injectors Market – BRICS Analysis
10.1 Overview
10.2 BRICS- 10.2.1 BRICS Needle-Free Injectors Market Breakdown, by Key Country, 2026 and 2033 (%)
- 10.2.1.1 BRICS Needle-Free Injectors Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 Russia: BRICS Needle-Free Injectors Market – Revenue and Forecast to 2033 (US$ Million)
- 10.2.1.1.1 Russia: BRICS Needle-Free Injectors Market Breakdown, by Product
- 10.2.1.1.2 Russia: BRICS Needle-Free Injectors Market Breakdown, by Usability
- 10.2.1.1.3 Russia: BRICS Needle-Free Injectors Market Breakdown, by Application
- 10.2.1.2 Brazil: BRICS Needle-Free Injectors Market – Revenue and Forecast to 2033 (US$ Million)
- 10.2.1.2.1 Brazil: BRICS Needle-Free Injectors Market Breakdown, by Product
- 10.2.1.2.2 Brazil: BRICS Needle-Free Injectors Market Breakdown, by Usability
- 10.2.1.2.3 Brazil: BRICS Needle-Free Injectors Market Breakdown, by Application
- 10.2.1.3 South Africa: BRICS Needle-Free Injectors Market – Revenue and Forecast to 2033 (US$ Million)
- 10.2.1.3.1 South Africa: BRICS Needle-Free Injectors Market Breakdown, by Product
- 10.2.1.3.2 South Africa: BRICS Needle-Free Injectors Market Breakdown, by Usability
- 10.2.1.3.3 South Africa: BRICS Needle-Free Injectors Market Breakdown, by Application
- 10.2.1.4 India: BRICS Needle-Free Injectors Market – Revenue and Forecast to 2033 (US$ Million)
- 10.2.1.4.1 India: BRICS Needle-Free Injectors Market Breakdown, by Product
- 10.2.1.4.2 India: BRICS Needle-Free Injectors Market Breakdown, by Usability
- 10.2.1.4.3 India: BRICS Needle-Free Injectors Market Breakdown, by Application
- 10.2.1.5 the UAE: BRICS Needle-Free Injectors Market – Revenue and Forecast to 2033 (US$ Million)
- 10.2.1.5.1 the UAE: BRICS Needle-Free Injectors Market Breakdown, by Product
- 10.2.1.5.2 the UAE: BRICS Needle-Free Injectors Market Breakdown, by Usability
- 10.2.1.5.3 the UAE: BRICS Needle-Free Injectors Market Breakdown, by Application
- 10.2.1.6 China: BRICS Needle-Free Injectors Market – Revenue and Forecast to 2033 (US$ Million)
- 10.2.1.6.1 China: BRICS Needle-Free Injectors Market Breakdown, by Product
- 10.2.1.6.2 China: BRICS Needle-Free Injectors Market Breakdown, by Usability
- 10.2.1.6.3 China: BRICS Needle-Free Injectors Market Breakdown, by Application
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Gerresheimer AG
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Becton Dickinson and Co
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Owen Mumford Ltd.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 West Pharmaceutical Services
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 SHL Medical
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 YPSOMED
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Phillips-Medisize
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Nemera
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 SMC Ltd
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 Haselmeier GmbH
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full B Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.